CMS and Opioids: The Role for Non-Drug Reimbursements
This article was originally published in RPM Report
Executive Summary
The Centers for Medicare and Medicaid Services proposed Part D rules to give plans some responsibility for monitoring opioid abuse. But providers at a Senate Finance Hearing think CMS reimbursements beyond drugs can have a role in screening abuse – and in treating pain to begin with.